CSL BEHRING AG

Company Introduction for CSL Behring AG in Turkey:

CSL Behring AG is a global biotherapeutics leader with a significant presence worldwide. While its global headquarters are located in King of Prussia, Pennsylvania, USA, it has a strong European footprint and operates through various subsidiaries globally. In Turkey, CSL Behring operates through its local commercial entity, CSL Behring İlaç Ticaret A.Ş.

The company is dedicated to developing and delivering innovative protein-based therapies that save lives and improve the quality of life for patients with serious and rare diseases. Its extensive product portfolio addresses critical needs in key therapeutic areas, including immunology (e.g., primary immunodeficiencies), hematology (e.g., hemophilia, von Willebrand disease), cardiovascular and metabolic disorders, respiratory conditions, and transplant medicine. CSL Behring is committed to scientific innovation and patient-centric solutions, ensuring access to its specialized medicines for those who need them most.

Is it a factory or a trader?

In Turkey, CSL Behring operates primarily as a commercial entity, functioning as a trader and distributor. It is responsible for the sales, marketing, and distribution of CSL Behring's global product portfolio within the Turkish market. It does not operate a manufacturing plant in Turkey. Its primary role in Turkey is to ensure patients have access to its specialized biopharmaceutical products.

CSL Behring AG, through its global operations and local presence in Turkey, primarily focuses on developing and distributing plasma-derived and recombinant biotherapies. While manufacturing typically occurs at its global facilities, the company sells and distributes a range of products in Turkey for various therapeutic areas. These products include:

Immunology

Privigen (Intravenous Immunoglobulin) for primary immunodeficiency, CIDP, and other immune disorders.

Hizentra (Subcutaneous Immunoglobulin) for primary immunodeficiency.

Gamunex-C (Intravenous Immunoglobulin) for primary immunodeficiency, ITP, and CIDP.

Hematology and Bleeding Disorders

Idelvion (Coagulation Factor IX (Recombinant), Albumin Fusion Protein) for Hemophilia B.

Afstyla (Antihemophilic Factor (Recombinant), SingleChain) for Hemophilia A.

Haemate P (Human plasma-derived Factor VIII/von Willebrand Factor concentrate) for Hemophilia A and von Willebrand Disease.

Berinin P (Coagulation Factor IX) for Hemophilia B.

Kcentra (Prothrombin Complex Concentrate (Human)) for urgent reversal of vitamin K antagonist therapy.

Corifact (Factor XIII Concentrate (Human)) for congenital Factor XIII deficiency.

Respiratory Diseases (Alpha-1 Antitrypsin Deficiency)

Zemaira (Alpha1-Proteinase Inhibitor (Human)).

Respreeza (Alpha1-Proteinase Inhibitor (Human)).

Prolastin-C (Alpha1-Proteinase Inhibitor (Human)).

Critical Care and Albumin

Albuminar (Human Albumin) for plasma volume expansion and protein replacement.

Beriplast P (Fibrin Sealant) for surgical hemostasis.

Hyperimmune Therapies

HyperRAB (Rabies Immune Globulin (Human)).

HyperHEP B (Hepatitis B Immune Globulin (Human)).

HyperTET (Tetanus Immune Globulin (Human)).

Cytogam (Cytomegalovirus Immune Globulin Intravenous (Human)).

Beriglobin P (Human Normal Immunoglobulin).